Ritter Pharmaceuticals Inc (RTTR): Knoll Capital Management Reports New Position

Page 3 of 7 – SEC Filing
Cusip No. 767836109 13G Page 3 of 7 Pages

1.

NAME OF REPORTING PERSONS

Fred Knoll

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(see instructions)

(a)     

(b)     

3.

SEC USE ONLY

4.

CITIZENSHIP OR PLACE OF ORGANIZATION

USA

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

5.

SOLE VOTING POWER

0

6.

SHARED VOTING POWER

 

526,903

7.

SOLE DISPOSITIVE POWER

0

8.

SHARED DISPOSITIVE POWER

526,903

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

526,903

10.

CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES

CERTAIN SHARES

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

6.14%

12.

TYPE OF REPORTING PERSON

IN

Page 3 of 7

Follow Qualigen Therapeutics Inc. (NASDAQ:QLGN)